Lifecare ASA

Lifecare ASA: Share capital increase registered

Reference is made to the stock exchange announcement made by Lifecare ASA (the

"Company") on 13 June 2025 regarding the final results following expiry of the

exercise period for the Warrants issued in connection with the Rights Issue. A

total of 3,207,994 Warrants were exercised, raising gross proceeds of NOK 17.1

million.

The share capital increase pertaining to the issuance of the new shares as

results of exercise of Warrants has now been registered with the Norwegian

99,117,059.60 divided into 19,060,973 shares, each with a nominal value of NOK

5.20.

The Shares are expected to be delivered to applicants in the VPS on or about

26 June 2025, subject to timely payment having been received.

About us

Lifecare ASA is a medical sensor company developing technology for sensing and

monitoring of various body analytes. Lifecare's focus is to bring the next

generation of Continuous Glucose Monitoring ("CGM") systems to market.

Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor

technology is suitable for identifying and monitoring the occurrence of a wide

range of analytes and molecules in the human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, [email protected], +47 40 05 90 40

Renete Kaarvik, CFO, [email protected], +47 94 83 82 42

This information is subject to disclosure under the Norwegian Securities

Trading Act, §5-12. The information was submitted for publication at

2025-06-25 14:10 CEST.

AI Terminal